慢性便秘和刺激性肠综合征与消化道癌症的因果关系:孟德尔的随机化研究
Rencai Fan1, Jiaqi Zhang1, Jiaofeng Shen1
1Department of Oncology, The Second Affiliated Hospital of Soochow University, No.1055, Sanxiang Road, Gusu District, Soochow 215004, Jiangsu Province, P.R. China.
Recent patents on anti-cancer drug discovery
|January 20, 2024
概括
便秘会增加胰腺癌的风险,刺激性肠综合征 (IBS) 与结直肠癌 (CRC) 的易感性有关. 这些疾病与其他消化道癌症之间的因果关系尚不清楚.
科学领域:
- 胃肠道学和瘤学
- 遗传流行病学遗传流行病学
背景情况:
- 慢性便秘和刺激性肠综合征 (IBS) 是常见的胃肠道疾病.
- 消化道癌症 (DTCs) 给全球健康带来了重大挑战.
- 现有研究对便秘,IBS和DTC风险之间的因果关系提供了有限的证据.
研究的目的:
- 调查便秘和IBS与七种DTC风险之间的潜在因果关系.
- 利用门德尔的随机化 (MR) 来评估这些关联.
主要方法:
- 孟德尔随机化 (MR) 分析是使用来自FinnGen数据库的遗传仪器变量 (IV) 进行的.
- 分析了七种DTC:结直肠癌 (CRC),肝细胞癌 (HCC),食道恶性瘤 (ESCA),胰腺腺癌 (PAAD),胆道癌 (BTC),胃癌 (GC) 和小肠瘤 (SIC).
- 使用了多种分析方法,包括IVW (MRE和FE),ML,WM,MR-Egger和MR-PRESSO.
主要成果:
- 基因预测的便秘与胰腺腺癌 (PAAD) 风险增加有显著的关联 (OR = 2.29).
- 基因预测IBS与异常值去除后结直肠癌 (CRC) (OR = 1.17) 的更高风险相关.
- 在便秘或IBS和其他DTC之间没有发现确的因果关系.
结论:
- 便秘与胰腺腺癌 (PAAD) 的风险增加有关.
- 刺激性肠综合征 (IBS) 与欧洲人口对结肠直肠癌 (CRC) 的易感性增加有关.
- 便秘,IBS和其他消化道癌症之间的因果关系需要进一步调查.
相关概念视频
Chronic Bowel Disorders: Introduction
455
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
455
Irritable Bowel Syndrome I: Introduction
276
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
276
Drugs for Treatment of Constipation-Predominant IBS
170
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
170
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
163
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
163
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Inflammatory Bowel Disease I: Ulcerative Colitis
187
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
187


